Heather A. Mitchell, Ph.D. - Publications

Emory University, Atlanta, GA

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Rigby MJ, Ding Y, Farrugia MA, Feig M, Cortese GP, Mitchell H, Burger C, Puglielli L. The endoplasmic reticulum acetyltransferases ATase1/NAT8B and ATase2/NAT8 are differentially regulated to adjust engagement of the secretory pathway. Journal of Neurochemistry. e14958. PMID 31945187 DOI: 10.1111/Jnc.14958  0.334
2018 Porter-Stransky KA, Centanni SW, Karne SL, Odil LM, Fekir S, Wong JC, Jerome C, Mitchell HA, Escayg A, Pedersen NP, Winder DG, Mitrano DA, Weinshenker D. Noradrenergic Transmission at Alpha1-Adrenergic Receptors in the Ventral Periaqueductal Gray Modulates Arousal. Biological Psychiatry. PMID 30269865 DOI: 10.1016/J.Biopsych.2018.07.027  0.572
2016 Hullinger R, Li M, Wang J, Peng Y, Dowell JA, Bomba-Warczak E, Mitchell HA, Burger C, Chapman ER, Denu JM, Li L, Puglielli L. Increased expression of AT-1/SLC33A1 causes an autistic-like phenotype in mice by affecting dendritic branching and spine formation. The Journal of Experimental Medicine. PMID 27242167 DOI: 10.1084/Jem.20151776  0.353
2011 Keebaugh AC, Mitchell HA, Gaval-Cruz M, Freeman KG, Edwards GL, Weinshenker D, Thomas JW. PRTFDC1 is a genetic modifier of HPRT-deficiency in the mouse. Plos One. 6: e22381. PMID 21818316 DOI: 10.1371/Journal.Pone.0022381  0.536
2010 Mitchell HA, Weinshenker D. Good night and good luck: norepinephrine in sleep pharmacology. Biochemical Pharmacology. 79: 801-9. PMID 19833104 DOI: 10.1016/J.Bcp.2009.10.004  0.557
2009 Mitchell HA, Bogenpohl JW, Liles LC, Epstein MP, Bozyczko-Coyne D, Williams M, Weinshenker D. Corrigendum to "Behavioral responses of dopamine β-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action" (DOI:10.1016/j.pbb.2008.07.014) Pharmacology Biochemistry and Behavior. 92: 197. DOI: 10.1016/j.pbb.2008.12.001  0.559
2008 Mitchell HA, Bogenpohl JW, Liles LC, Epstein MP, Bozyczko-Coyne D, Williams M, Weinshenker D. Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action. Pharmacology, Biochemistry, and Behavior. 91: 217-22. PMID 18703079 DOI: 10.1016/J.Pbb.2008.07.014  0.628
2006 Mitchell HA, Ahern TH, Liles LC, Javors MA, Weinshenker D. The effects of norepinephrine transporter inactivation on locomotor activity in mice. Biological Psychiatry. 60: 1046-52. PMID 16893531 DOI: 10.1016/J.Biopsych.2006.03.057  0.567
2006 Ahern TH, Javors MA, Eagles DA, Martillotti J, Mitchell HA, Liles LC, Weinshenker D. The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 730-8. PMID 16052243 DOI: 10.1038/Sj.Npp.1300847  0.514
2005 Wang HW, Babic AM, Mitchell HA, Liu K, Wagner DD. Elevated soluble ICAM-1 levels induce immune deficiency and increase adiposity in mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1018-20. PMID 15817637 DOI: 10.1096/Fj.04-3094Fje  0.368
2003 Cambien B, Bergmeier W, Saffaripour S, Mitchell HA, Wagner DD. Antithrombotic activity of TNF-alpha. The Journal of Clinical Investigation. 112: 1589-96. PMID 14617760 DOI: 10.1172/Jci19284  0.315
Show low-probability matches.